PT Tempo Scan Pacific Tbk (ISX:TSPC) EBITDA Margin %: 13.93% (As of Mar. 2026) — 18% Above Median


ISX:TSPC PT Tempo Scan Pacific Tbk ISX:TSPC
93 GF Score
Price Rp2,480.00
GF Value Rp2,448.15
Valuation Fairly Valued
View Full Analysis

What is PT Tempo Scan Pacific Tbk EBITDA Margin %?

PT Tempo Scan Pacific Tbk ISX:TSPC 93 EBITDA Margin % is 13.93% as of Mar. 2026, which is 18% above its 10-year median of 11.83. GuruFocus rates ISX:TSPC with a GF Score™ of 93/100 and a GF Value™ of Rp2,448.15 (Fairly Valued). Among 549 Conglomerates companies, PT Tempo Scan Pacific Tbk ranks better than 57.92% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PT Tempo Scan Pacific Tbk's EBITDA for the three months ended in Mar. 2026 was Rp475,430 Mil. PT Tempo Scan Pacific Tbk's Revenue for the three months ended in Mar. 2026 was Rp3,413,260 Mil. Therefore, PT Tempo Scan Pacific Tbk's EBITDA margin for the quarter that ended in Mar. 2026 was 13.93%.


PT Tempo Scan Pacific Tbk  (ISX:TSPC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


PT Tempo Scan Pacific Tbk EBITDA Margin % Related Terms


PT Tempo Scan Pacific Tbk EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for PT Tempo Scan Pacific Tbk's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Tempo Scan Pacific Tbk EBITDA Margin % Chart

PT Tempo Scan Pacific Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.89 12.95 14.26 16.93 14.89

PT Tempo Scan Pacific Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.75 12.75 18.53 10.97 13.93

ISX:TSPC vs HON, MMM: EBITDA Margin % Comparison

For the Conglomerates subindustry, PT Tempo Scan Pacific Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Tempo Scan Pacific Tbk EBITDA Margin % vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, PT Tempo Scan Pacific Tbk's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PT Tempo Scan Pacific Tbk's EBITDA Margin % falls into.


ISX:TSPC
93GF Score
PT Tempo Scan Pacific Tbk ISX:TSPC
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Tempo Scan Pacific Tbk EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PT Tempo Scan Pacific Tbk's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=2084918.706/14005028.134
=14.89 %

PT Tempo Scan Pacific Tbk's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=475429.841/3413260.289
=13.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 13.93% mean?
PT Tempo Scan Pacific Tbk (ISX:TSPC) has a EBITDA Margin % of 13.93% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Tempo Scan Pacific Tbk and its competitors. This is 18% above median its historical median of 11.83. Over the past decade, PT Tempo Scan Pacific Tbk's EBITDA Margin % has ranged from 8.78 to 16.93. According to the industry distribution chart, PT Tempo Scan Pacific Tbk ranks #231 out of 549 companies in the Conglomerates industry, placing it in the top 42.1%.
Is PT Tempo Scan Pacific Tbk's EBITDA Margin % too high?
PT Tempo Scan Pacific Tbk's current EBITDA Margin % of 13.93% is 18% above median its 10-year median of 11.83. Over the past 10 years, this metric has ranged from a low of 8.78 to a high of 16.93. The Conglomerates industry median EBITDA Margin % is 12.24. PT Tempo Scan Pacific Tbk's value of 13.93% is 13.8% above this industry median. Based on the distribution chart, PT Tempo Scan Pacific Tbk ranks #231 out of 549 companies in the Conglomerates industry, which is above the industry midpoint. Overall, PT Tempo Scan Pacific Tbk has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Tempo Scan Pacific Tbk's EBITDA Margin % compare to HON and MMM?
According to the Conglomerates industry distribution chart, PT Tempo Scan Pacific Tbk ranks #231 out of 549 companies for EBITDA Margin %. This puts PT Tempo Scan Pacific Tbk in the upper half of its industry. The industry median EBITDA Margin % is 12.24. PT Tempo Scan Pacific Tbk's value of 13.93% is 13.8% above this benchmark. Historically, PT Tempo Scan Pacific Tbk's own EBITDA Margin % has ranged from 8.78 to 16.93 over the past decade. While the company's 10-year median is 11.83 vs. the industry median of 12.24, PT Tempo Scan Pacific Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Conglomerates company?
The median EBITDA Margin % among Conglomerates companies is 12.24, based on 549 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Tempo Scan Pacific Tbk's current EBITDA Margin % of 13.93% is 13.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Tempo Scan Pacific Tbk and its competitors. For the Conglomerates industry, the median EBITDA Margin % is 12.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Tempo Scan Pacific Tbk's current EBITDA Margin % is 13.93%, which is 18% above median its own 10-year median of 11.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Tempo Scan Pacific Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Tempo Scan Pacific Tbk (ISX:TSPC) is currently considered Fairly Valued. The stock's GF Value™ is Rp2,448.15, compared to a current price of Rp2,480.00 — trading 1.3% above its estimated fair value. The current EBITDA Margin % is 13.93%, which is 18% above median its 10-year median of 11.83 and 13.8% above the Conglomerates industry median of 12.24. PT Tempo Scan Pacific Tbk's overall GF Score™ is 93/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Tempo Scan Pacific Tbk (ISX:TSPC), the current EBITDA Margin % is 13.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Tempo Scan Pacific Tbk (ISX:TSPC) Overvalued in 2026?

Based on GuruFocus' analysis, PT Tempo Scan Pacific Tbk stock appears to be overvalued. The current stock price of Rp2,480.00 is trading 1.3% above its estimated GF Value™ of Rp2,448.15. GuruFocus considers PT Tempo Scan Pacific Tbk to be Fairly Valued.

Key valuation signals for ISX:TSPC:

  • EBITDA Margin %: 13.93% (18% above median its 10-year median of 11.83)
  • GF Value™: Rp2,448.15 vs. price of Rp2,480.00 (1.3% above fair value)
  • GF Score™: 93/100
  • Industry Position: 13.8% above the Conglomerates median (#231 of 549)

No single metric tells the full story. See the ISX:TSPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Tempo Scan Pacific Tbk Business Description

Address Jalan H.R. Rasuna Said Kav. 3-4, Tempo Scan Tower, 16th Floor, Jakarta, IDN, 12950
PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms, and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.
93GF Score

Get the complete analysis for ISX:TSPC

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp2,480.00
Price
Rp2,448.15
GF Value